"The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP). The device, which includes a small video camera, transmitter "...
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
RANIBIZUMAB - INTRAOCULAR
COMMON BRAND NAME(S): Lucentis
USES: This medication is used to treat a certain serious eye condition (age-related macular degeneration). It is used to help prevent decreased vision and blindness. Ranibizumab works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels.
HOW TO USE: This medication is given by injection into the affected eye(s) by a health care professional. The affected eye is numbed before each injection. After the injection, you will remain in the doctor's office for a while, and your eye will be monitored.
Dosage is based on your medical condition and response to treatment. This medication is usually given once a month or as directed by your doctor. If you are not able to have monthly injections, your doctor may change your schedule after the first few injections to once every 3 months.
Use this medication regularly to get the most benefit from it.
Tell your doctor if your condition does not improve or if it worsens.
Additional Lucentis Information
Lucentis - User Reviews
Lucentis User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get breaking medical news.